Alnylam Pharmaceuticals (ALNY.MX) Q1 2016 Earnings

11FebConfirmed
Q2 2015
Q3 2015
Q4 2015
Q1 2016
-20.49
-16.83
-13.16
-9.49

Details

Expected EPS
-18.385728
Actual EPS
-20.492426000000002
Surprise EPS
-2.11
Surprise Percent
+11.46%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -20.492426000000002 per share for Q1 2016.

0 Comments

Share your thoughts